Literature DB >> 11393061

Bronchoalveolar lavage fluid cytology in patients with Pneumocystis carinii pneumonia.

J A Jacobs1, M M Dieleman, E I Cornelissen, E A Groen, S S Wagenaar, M Drent.   

Abstract

OBJECTIVE: To evaluate bronchoalveolar lavage (BAL) cytology and organism burden in patients with Pneumocystis carinii pneumonia (PCP) who were infected with the human immunodeficiency virus (HIV) and in those with other immunodeficiencies. STUDY
DESIGN: BAL fluid samples from patients with PCP were selected (HIV-infected patients, n = 15; patients with other immunodeficiencies, n = 11). May-Grünwald-Giemsa-stained cytocentrifuge preparations were evaluated. Foamy alveolar casts (FACs) and P carinii clusters were counted.
RESULTS: The numbers of FACs and P carinii clusters in BAL fluid samples of HIV-infected patients were significantly higher as compared to those in samples from patients with other immunodeficiencies. Striking cytologic findings observed in half the samples from both patient groups included the presence of foamy alveolar macrophages, activated lymphocytes, plasma cells and reactive type II pneumocytes. Furthermore, a peculiar cell type, "nonidentified cell" (NIC), was observed almost exclusively in BAL fluid samples from HIV-infected patients.
CONCLUSION: BAL fluid samples from HIV-infected patients with PCP displayed higher organism burdens as compared to those from patients with other immunodeficiencies. Moreover, cytologic findings suggestive of noninfectious lung conditions were common in BAL fluid samples obtained from patients with PCP. Further study is required to elucidate the identity of the NIC cell type.

Entities:  

Mesh:

Year:  2001        PMID: 11393061     DOI: 10.1159/000327625

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  9 in total

1.  Development and Evaluation of Rapid and Accurate CRISPR/Cas13-Based RNA Diagnostics for Pneumocystis jirovecii Pneumonia.

Authors:  Yangqing Zhan; Xiaoqing Gao; Shaoqiang Li; Yeqi Si; Yuanxiang Li; Xu Han; Wenjun Sun; Zhengtu Li; Feng Ye
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

2.  Influence of antibiotic therapy on the cytological diagnosis of ventilator-associated pneumonia.

Authors:  Catharina F M Linssen; Jan A Jacobs; Jan S A G Schouten; Walther N K A van Mook; Graham Ramsay; Marjolein Drent
Journal:  Intensive Care Med       Date:  2008-02-05       Impact factor: 17.440

3.  Bronchoalveolar lavage cytological alveolar damage in patients with severe pneumonia.

Authors:  Bogdan Grigoriu; Frédéric Jacobs; Fabienne Beuzen; Rony El Khoury; Olivier Axler; Francois G Brivet; Frédérique Capron
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

4.  SARS-CoV-2 and superimposed infection by trichomonads.

Authors:  Christophe Duboucher
Journal:  J Infect       Date:  2020-11-30       Impact factor: 6.072

5.  Low cut-off value of serum (1,3)-beta-D-glucan for the diagnosis of Pneumocystis pneumonia in non-HIV patients: a retrospective cohort study.

Authors:  Jumpei Taniguchi; Kei Nakashima; Hiroki Matsui; Tomohisa Watari; Ayumu Otsuki; Hiroyuki Ito; Yoshihito Otsuka
Journal:  BMC Infect Dis       Date:  2021-11-29       Impact factor: 3.090

6.  Pneumocystis carinii pneumonia in gastric cancer patients without acquired immune deficiency syndrome: 3 cases report and literature review.

Authors:  So Young Yoon; Hyun Kyun Ki; Sung Yong Kim; Yo Han Cho; Hong Ghi Lee; Moon-Won Yoo
Journal:  J Korean Surg Soc       Date:  2012-06-26

7.  Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection.

Authors:  Xavier Monnet; Emmanuelle Vidal-Petiot; David Osman; Olfa Hamzaoui; Antoine Durrbach; Cécile Goujard; Corinne Miceli; Patrice Bourée; Christian Richard
Journal:  Crit Care       Date:  2008-01-25       Impact factor: 9.097

8.  Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia.

Authors:  Virginie Lemiale; Alexandre Debrumetz; Alexandra Delannoy; Corinne Alberti; Elie Azoulay
Journal:  Respir Res       Date:  2013-08-28

9.  Three cases of presumed pneumocystis pneumonia in patients receiving bortezomib therapy for multiple myeloma.

Authors:  Christopher D Swan; Alistair B Reid
Journal:  IDCases       Date:  2014-05-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.